BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32215686)

  • 1. Stress-induced impairment in fear discrimination is causally related to increased kynurenic acid formation in the prefrontal cortex.
    Klausing AD; Fukuwatari T; Bucci DJ; Schwarcz R
    Psychopharmacology (Berl); 2020 Jul; 237(7):1931-1941. PubMed ID: 32215686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenalectomy exacerbates stress-induced impairment in fear discrimination: A causal role for kynurenic acid?
    Klausing AD; Fukuwatari T; DeAngeli N; Bucci DJ; Schwarcz R
    Biochem Pharmacol; 2024 Jun; ():116350. PubMed ID: 38852644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex.
    Beggiato S; Tanganelli S; Fuxe K; Antonelli T; Schwarcz R; Ferraro L
    Neuropharmacology; 2014 Jul; 82():11-8. PubMed ID: 24607890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.
    Koshy Cherian A; Gritton H; Johnson DE; Young D; Kozak R; Sarter M
    Neuropharmacology; 2014 Jul; 82():41-8. PubMed ID: 24647121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry.
    Konradsson-Geuken A; Wu HQ; Gash CR; Alexander KS; Campbell A; Sozeri Y; Pellicciari R; Schwarcz R; Bruno JP
    Neuroscience; 2010 Sep; 169(4):1848-59. PubMed ID: 20600676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.
    Wu HQ; Pereira EF; Bruno JP; Pellicciari R; Albuquerque EX; Schwarcz R
    J Mol Neurosci; 2010 Jan; 40(1-2):204-10. PubMed ID: 19690987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal THC exposure raises kynurenic acid levels in the prefrontal cortex of adult rats.
    Beggiato S; Ieraci A; Tomasini MC; Schwarcz R; Ferraro L
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109883. PubMed ID: 32032697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of brain kynurenic acid improves cognitive function.
    Kozak R; Campbell BM; Strick CA; Horner W; Hoffmann WE; Kiss T; Chapin DS; McGinnis D; Abbott AL; Roberts BM; Fonseca K; Guanowsky V; Young DA; Seymour PA; Dounay A; Hajos M; Williams GV; Castner SA
    J Neurosci; 2014 Aug; 34(32):10592-602. PubMed ID: 25100593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.
    Bortz DM; Wu HQ; Schwarcz R; Bruno JP
    Neuropharmacology; 2017 Jul; 121():69-78. PubMed ID: 28419874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine.
    Alexander KS; Pocivavsek A; Wu HQ; Pershing ML; Schwarcz R; Bruno JP
    Neuroscience; 2013 May; 238():19-28. PubMed ID: 23395862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning.
    Chess AC; Landers AM; Bucci DJ
    Behav Brain Res; 2009 Aug; 201(2):325-31. PubMed ID: 19428652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain.
    Ceresoli-Borroni G; Rassoulpour A; Wu HQ; Guidetti P; Schwarcz R
    J Neural Transm (Vienna); 2006 Oct; 113(10):1355-65. PubMed ID: 16465454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in extracellular kynurenic acid concentrations in rat prefrontal cortex after D-kynurenine infusion: an in vivo microdialysis study.
    Ogaya T; Song Z; Ishii K; Fukushima T
    Neurochem Res; 2010 Apr; 35(4):559-63. PubMed ID: 19941066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding.
    Pershing ML; Phenis D; Valentini V; Pocivavsek A; Lindquist DH; Schwarcz R; Bruno JP
    Psychopharmacology (Berl); 2016 Oct; 233(21-22):3725-3735. PubMed ID: 27527585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to kynurenic acid during adolescence produces memory deficits in adulthood.
    Akagbosu CO; Evans GC; Gulick D; Suckow RF; Bucci DJ
    Schizophr Bull; 2012 Jun; 38(4):769-78. PubMed ID: 21172906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in rat prefrontal cortex kynurenic acid levels are involved in the enduring cognitive dysfunctions induced by tetrahydrocannabinol exposure during the adolescence.
    Beggiato S; Ieraci A; Zuccarini M; Di Iorio P; Schwarcz R; Ferraro L
    Front Psychiatry; 2022; 13():996406. PubMed ID: 36483135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release.
    Zmarowski A; Wu HQ; Brooks JM; Potter MC; Pellicciari R; Schwarcz R; Bruno JP
    Eur J Neurosci; 2009 Feb; 29(3):529-38. PubMed ID: 19187269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytic Mechanisms Involving Kynurenic Acid Control Δ
    Secci ME; Mascia P; Sagheddu C; Beggiato S; Melis M; Borelli AC; Tomasini MC; Panlilio LV; Schindler CW; Tanda G; Ferré S; Bradberry CW; Ferraro L; Pistis M; Goldberg SR; Schwarcz R; Justinova Z
    Mol Neurobiol; 2019 May; 56(5):3563-3575. PubMed ID: 30151725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
    Wu HQ; Rassoulpour A; Schwarcz R
    J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior.
    Potter MC; Elmer GI; Bergeron R; Albuquerque EX; Guidetti P; Wu HQ; Schwarcz R
    Neuropsychopharmacology; 2010 Jul; 35(8):1734-42. PubMed ID: 20336058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.